MediPharm Labs Corp. (TSX:LABS)
Canada · Delayed Price · Currency is CAD 0.0750
+0.0050 (7.14%)
Jun 12, 2026, 3:33 PM EST
MediPharm Labs Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8.75 | -8.27 | -10.69 | -13.08 | -29.98 | -54.8 |
Depreciation & Amortization | 1.62 | 1.66 | 2.6 | 2.52 | 2.87 | 5.63 |
Stock-Based Compensation | 1.06 | 1.34 | 0.98 | 2.03 | 2.87 | 2.4 |
Other Adjustments | -0.09 | -0.22 | 0.61 | -7.25 | 1.93 | 27.2 |
Change in Receivables | 1.21 | -0.06 | -1.56 | 6.29 | 3.62 | 5.93 |
Changes in Inventories | 2.13 | 0.99 | 0.8 | 3.11 | -0.1 | 2.49 |
Changes in Accounts Payable | -1.5 | 0.65 | 1.87 | -5.17 | 1.49 | -8.11 |
Changes in Accrued Expenses | 0.6 | -1.78 | 0.41 | 0.15 | -0.52 | 1.09 |
Changes in Income Taxes Payable | - | - | - | 0.13 | -0.01 | 4.26 |
Changes in Other Operating Activities | 0.34 | 0.18 | 0.14 | -1.07 | 1.75 | 0.7 |
Operating Cash Flow | -3.32 | -5.5 | -4.86 | -12.34 | -16.07 | -13.21 |
Capital Expenditures | -0.06 | -0.1 | -0.15 | -0.47 | -0.86 | -0.78 |
Sale of Property, Plant & Equipment | 2.6 | 4.72 | 0.57 | 2.08 | 0.01 | 0.82 |
Proceeds from Business Divestments | - | - | - | 4.25 | 6.01 | - |
Other Investing Activities | - | - | - | 1.01 | - | - |
Investing Cash Flow | 4.66 | 4.62 | 0.41 | 6.87 | 5.16 | 0.04 |
Long-Term Debt Issued | 0.25 | 0.5 | 0.8 | 1.07 | 1.34 | - |
Long-Term Debt Repaid | -0.51 | -0.61 | -2.92 | -1.76 | -0.82 | -2.63 |
Net Long-Term Debt Issued (Repaid) | -0.26 | -0.11 | -2.12 | -0.7 | 0.52 | -2.63 |
Issuance of Common Stock | - | - | 0.01 | - | - | 30.92 |
Net Common Stock Issued (Repurchased) | - | - | 0.01 | - | - | 30.92 |
Other Financing Activities | 0.07 | 0.09 | 0.26 | 0.33 | 0.27 | -0.48 |
Financing Cash Flow | 0.05 | -0.02 | -1.85 | -0.37 | 0.8 | 27.8 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.03 | 0.02 | 0 | -0.33 | 0.15 | -0.43 |
Net Cash Flow | 1.42 | -0.88 | -6.29 | -6.16 | -9.97 | 14.2 |
Free Cash Flow | -3.38 | -5.6 | -5.02 | -12.81 | -16.93 | -14 |
FCF Margin | -7.80% | -12.42% | -11.95% | -38.75% | -76.56% | -64.46% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.04 | -0.06 | -0.06 |
Levered Free Cash Flow | -5.89 | -6.78 | -7.15 | -14.58 | -24.83 | -52.16 |
Unlevered Free Cash Flow | -5.78 | -6.84 | -5.15 | -19.43 | -24.91 | -43.54 |